Skip to main content
. 2019 Apr 12;116(15):253–260. doi: 10.3238/arztebl.2019.0253

Table 1. Key data from included studies.

Authors
(reference)
Publication year Study design Number of patients*1
(M–F)*2
Mean follow-up period
(range)
Patients‘ mean age
in years
(range)
Evaluation of quality of life
(abbreviations of questionnaires
used)
Ainsworth et al. (22) 2010 Cross sectional study n = 247 Not available 50 SF-36
Bouman et al. (27) 2016 Cross sectional study n = 31 2.2 years
(0.8–7.5)
19.1
(18.3–45.0)
SHS, SWLS, CLLS
Cardoso da Silva et al. (26) 2016 Prospective cohort study n = 47 At least 1 year 31.23
(16–54)
WHOQOL-100
Castellano et al. (17) 2015 Case–control study n = 120
(46 M–F and 14 F–M)
At least 2 years 39.0
(18–65)
WHOQOL-100
(Control group:
45 cis women and
15 cis men)
Control group:
40.2 (18–65)
Jokic-Begic et al. (18) 2014 Cross sectional study n = 6
(3 M–F and 3 F–M)
At least 3 months 33.83
(24–42)
SF-36,
semi-structured interview
Kuhn et al. (19) 2009 Case–control study n = 75
(52 M–F and 3 F–M)
15 years
(8–23)
51
(39–62)
KHQ, VAS
Control group:
(20 cis women)
Control group:
49 (37–60)
Lindqvist et al. (23) 2016 Prospective cohort study n = 190 3 years
(1–5)
36
(19–76)
SF-36
Papadopulos et al. (29) 2017 Cross sectional study n = 47 19 months
(6–58)
38,3
(18–57)
FLZ
Parola et al. (20) 2010 Cross sectional study n = 30
(15 M–F and 15 F–M)
At least 2 years 48,5
(32–65)
SF-36,
semi-structured interview
van der Sluis et al. (28) 2016 Cohort study n = 9 29.6 years
(17.2–34.3)
58
(50–73)
SHS, SWLS, CLLS
Weyers et al. (24) 2009 Cohort study n = 50 At least 6 months 43.06 SF-36, VAS
Yang et al. (25) 2016 Cross sectional study n = 209 Not available 26.7
(18–45)
SF-36
Zimmermann et al. (21) 2006 Cross sectional study n = 40
(24 M–F and 16 F–M)
3.1 years
(0.5–19)
38
(23–51; 41.0 years for M–F)
FLZ

*1Numbers of study participants after removal of dropouts (table 2); exception: Lindqvist et al. (23), see Table 2

*2 M–F, male-to-female; F–M, female to male, sex reassignment surgery